| http://purl.uniprot.org/citations/20872251 | http://www.w3.org/1999/02/22-rdf-syntax-ns#type | http://purl.uniprot.org/core/Journal_Citation |
| http://purl.uniprot.org/citations/20872251 | http://www.w3.org/2000/01/rdf-schema#comment | "We aimed to determine the diagnostic performance of biomarkers in predicting myocardial fibrosis assessed by late gadolinium enhancement (LGE) cardiovascular magnetic resonance imaging (CMR) in patients with hypertrophic cardiomyopathy (HCM). LGE CMR was performed in 40 consecutive patients with HCM. Left and right ventricular parameters, as well as the extent of LGE were determined and correlated to the plasma levels of midregional pro-atrial natriuretic peptide (MR-proANP), midregional pro-adrenomedullin (MR-proADM), carboxy-terminal pro-endothelin-1 (CT-proET-1), carboxy-terminal pro-vasopressin (CT-proAVP), matrix metalloproteinase-9 (MMP-9), tissue inhibitor of metalloproteinase-1 (TIMP-1) and interleukin-8 (IL-8). Myocardial fibrosis was assumed positive, if CMR indicated LGE. LGE was present in 26 of 40 patients with HCM (65%) with variable extent (mean: 14%, range: 1.3-42%). The extent of LGE was positively associated with MR-proANP (r = 0.4; P = 0.01). No correlations were found between LGE and MR-proADM (r = 0.1; P = 0.5), CT-proET-1 (r = 0.07; P = 0.66), CT-proAVP (r = 0.16; P = 0.3), MMP-9 (r = 0.01; P = 0.9), TIMP-1 (r = 0.02; P = 0.85), and IL-8 (r = 0.02; P = 0.89). After adjustment for confounding factors, MR-proANP was the only independent predictor associated with the presence of LGE (P = 0.007) in multivariate analysis. The area under the ROC curve (AUC) indicated good predictive performance (AUC = 0.882) of MR-proANP with respect to LGE. The odds ratio was 1.268 (95% confidence interval 1.066-1.508). The sensitivity of MR-proANP at a cut-off value of 207 pmol/L was 69%, the specificity 94%, the positive predictive value 90% and the negative predictive value 80%. The results imply that MR-proANP serves as a novel marker of myocardial fibrosis assessed by LGE CMR in patients with HCM."xsd:string |
| http://purl.uniprot.org/citations/20872251 | http://purl.org/dc/terms/identifier | "doi:10.1007/s10554-010-9704-2"xsd:string |
| http://purl.uniprot.org/citations/20872251 | http://purl.uniprot.org/core/author | "Lang S."xsd:string |
| http://purl.uniprot.org/citations/20872251 | http://purl.uniprot.org/core/author | "Weiss C."xsd:string |
| http://purl.uniprot.org/citations/20872251 | http://purl.uniprot.org/core/author | "Borggrefe M."xsd:string |
| http://purl.uniprot.org/citations/20872251 | http://purl.uniprot.org/core/author | "Fluechter S."xsd:string |
| http://purl.uniprot.org/citations/20872251 | http://purl.uniprot.org/core/author | "Kalsch T."xsd:string |
| http://purl.uniprot.org/citations/20872251 | http://purl.uniprot.org/core/author | "Elmas E."xsd:string |
| http://purl.uniprot.org/citations/20872251 | http://purl.uniprot.org/core/author | "Schoenberg S.O."xsd:string |
| http://purl.uniprot.org/citations/20872251 | http://purl.uniprot.org/core/author | "Haghi D."xsd:string |
| http://purl.uniprot.org/citations/20872251 | http://purl.uniprot.org/core/author | "Kunde J."xsd:string |
| http://purl.uniprot.org/citations/20872251 | http://purl.uniprot.org/core/author | "Papassotiriou J."xsd:string |
| http://purl.uniprot.org/citations/20872251 | http://purl.uniprot.org/core/author | "Doesch C."xsd:string |
| http://purl.uniprot.org/citations/20872251 | http://purl.uniprot.org/core/author | "Freundt M."xsd:string |
| http://purl.uniprot.org/citations/20872251 | http://purl.uniprot.org/core/author | "Papavassiliu T."xsd:string |
| http://purl.uniprot.org/citations/20872251 | http://purl.uniprot.org/core/date | "2011"xsd:gYear |
| http://purl.uniprot.org/citations/20872251 | http://purl.uniprot.org/core/name | "Int J Cardiovasc Imaging"xsd:string |
| http://purl.uniprot.org/citations/20872251 | http://purl.uniprot.org/core/pages | "547-556"xsd:string |
| http://purl.uniprot.org/citations/20872251 | http://purl.uniprot.org/core/title | "Midregional pro-atrial natriuretic peptide: a novel marker of myocardial fibrosis in patients with hypertrophic cardiomyopathy."xsd:string |
| http://purl.uniprot.org/citations/20872251 | http://purl.uniprot.org/core/volume | "27"xsd:string |
| http://purl.uniprot.org/citations/20872251 | http://www.w3.org/2004/02/skos/core#exactMatch | http://purl.uniprot.org/pubmed/20872251 |
| http://purl.uniprot.org/citations/20872251 | http://xmlns.com/foaf/0.1/primaryTopicOf | https://pubmed.ncbi.nlm.nih.gov/20872251 |
| http://purl.uniprot.org/uniprot/#_B0ZBE8-mappedCitation-20872251 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/20872251 |
| http://purl.uniprot.org/uniprot/#_P01160-mappedCitation-20872251 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/20872251 |